TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention
Brief Summary: This study will determine whether a group cognitive-behavioral therapy intervention that demonstrates preliminary evidence of reducing alcohol use among HIV-infected outpatients in western Kenya is effective when compared against a group health education intervention in a large sample over a longer period of time. It will be delivered by paraprofessionals, individuals with limited formal education and little or no relevant professional experience. This approach is consistent with successful cost-effective models of service delivery in resource-limited settings in which paraprofessionals (e.g., clinical officers, traditional birth attendants and peer counselors) are trained.


Options:
A: Arm Label: HSKA - Web Group; Type: EXPERIMENTAL; Interventions: Behavioral: Her Sey Kontrol Altinda (HSKA) | Arm Label: HSKA - Mobile Group; Type: EXPERIMENTAL; Interventions: Behavioral: Her Sey Kontrol Altinda (HSKA) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Her Sey Kontrol Altinda (HSKA); Assigned to Arm(s): HSKA - Mobile Group, HSKA - Web Group
B: Arm Label: CBT; Type: EXPERIMENTAL; Interventions: Behavioral: CBT | Arm Label: HIV support group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HIV support group | Intervention Type: BEHAVIORAL; Name: HIV support group; Assigned to Arm(s): HIV support group | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): CBT
C: Arm Label: cognitive behavioral group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: cognitive behavioral group therapy | Arm Label: health education group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: health education group | Intervention Type: BEHAVIORAL; Name: cognitive behavioral group therapy; Assigned to Arm(s): cognitive behavioral group therapy | Intervention Type: BEHAVIORAL; Name: health education group; Assigned to Arm(s): health education group
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PC101+Mental Health | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PC101+Mental Health | Intervention Type: BEHAVIORAL; Name: PC101+Mental Health; Assigned to Arm(s): Control, Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Definitive Phase III Study of the Effects of Ferric Citrate on Serum Phosphate in Subjects With End Stage Renal Disease
Brief Summary: The purpose of the study is to determine the effect and optimum dose and evaluate the safety of ferric citrate, administered three times daily (TID) immediately after meals for a total daily dose of 4 or 6 grams for 56 days, on serum phosphate (PO4) levels in subjects with end stage renal disease (ESRD).


Options:
A: Arm Label: HS219; Type: EXPERIMENTAL; Interventions: Dietary Supplement: HS219 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: HS219; Assigned to Arm(s): HS219 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: ferric citrate | Arm Label: 4g/day; Type: EXPERIMENTAL; Interventions: Drug: ferric citrate | Arm Label: 6g/day; Type: EXPERIMENTAL; Interventions: Drug: ferric citrate | Intervention Type: DRUG; Name: ferric citrate; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: ferric citrate; Assigned to Arm(s): 4g/day | Intervention Type: DRUG; Name: ferric citrate; Assigned to Arm(s): 6g/day
C: Arm Label: Sevelamer HCl; Type: EXPERIMENTAL; Interventions: Drug: Sevelamer HCl | Arm Label: Calcium-based binder; Type: ACTIVE_COMPARATOR; Interventions: Drug: Calcium-based phosphate binder | Intervention Type: DRUG; Name: Sevelamer HCl; Assigned to Arm(s): Sevelamer HCl | Intervention Type: DRUG; Name: Calcium-based phosphate binder; Assigned to Arm(s): Calcium-based binder
D: Arm Label: Arm 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: SBR759A | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Arm Label: arm 4; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Arm Label: arm 5; Type: EXPERIMENTAL; Interventions: Drug: SBR759A | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): arm 4 | Intervention Type: DRUG; Name: SBR759A; Assigned to Arm(s): arm 5

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Cardiovascular Management Study: A Cluster-Randomized Trial to Evaluate the Effects of a Simplified Cardiovascular Management Program in Tibet, China and Haryana, India
Brief Summary: The goal of this study is to develop, pilot test, and evaluate a highly simplified but guideline-based program for cardiovascular management for application in resource-scarce settings. The study aims to assess the effects of implementing a simple low-cost cardiovascular management program for high-risk individuals, delivered by primary care providers (PCPs) or community health workers (CHWs), on the proportion of patients appropriately treated with diuretics as well as a number of secondary outcomes in resource-scarce Tibet, China and Haryana India.


Options:
A: Arm Label: Immediate Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Immediate Intervention | Arm Label: Wait List Intervention; Type: OTHER; Interventions: Other: Wait List Intervention | Intervention Type: BEHAVIORAL; Name: Immediate Intervention; Assigned to Arm(s): Immediate Intervention | Intervention Type: OTHER; Name: Wait List Intervention; Assigned to Arm(s): Wait List Intervention
B: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Life style Intervention and care coordination; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated cardiovascular disease risk management. | Intervention Type: BEHAVIORAL; Name: Integrated cardiovascular disease risk management.; Assigned to Arm(s): Life style Intervention and care coordination
C: Arm Label: Health check; Type: EXPERIMENTAL; Interventions: Other: Health check | Arm Label: No invitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Health check; Assigned to Arm(s): Health check
D: Arm Label: Control (Usual Care); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Simplified cardiovascular disease management | Intervention Type: OTHER; Name: Simplified cardiovascular disease management; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Cardiovascular Management Study: A Cluster-Randomized Trial to Evaluate the Effects of a Simplified Cardiovascular Management Program in Tibet, China and Haryana, India
Brief Summary: The goal of this study is to develop, pilot test, and evaluate a highly simplified but guideline-based program for cardiovascular management for application in resource-scarce settings. The study aims to assess the effects of implementing a simple low-cost cardiovascular management program for high-risk individuals, delivered by primary care providers (PCPs) or community health workers (CHWs), on the proportion of patients appropriately treated with diuretics as well as a number of secondary outcomes in resource-scarce Tibet, China and Haryana India.


Options:
A: Arm Label: Intervention; Type: OTHER; Interventions: Behavioral: Vascular Management Program, Behavioral: Clinical Care Coordinators, Behavioral: Web-based Vascular Tracker for Patient and Physician, Behavioral: Automated Telephone Reminder System | Intervention Type: BEHAVIORAL; Name: Vascular Management Program; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Clinical Care Coordinators; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Web-based Vascular Tracker for Patient and Physician; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Automated Telephone Reminder System; Assigned to Arm(s): Intervention
B: Arm Label: Framingham Risk Score; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Framingham and Genetic Risk Score; Type: ACTIVE_COMPARATOR; Interventions: Other: Genetic Risk Score | Intervention Type: OTHER; Name: Genetic Risk Score; Assigned to Arm(s): Framingham and Genetic Risk Score
C: Arm Label: Information Support System; Type: EXPERIMENTAL; Interventions: Other: Information Support System | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Information Support System; Assigned to Arm(s): Information Support System
D: Arm Label: Control (Usual Care); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Simplified cardiovascular disease management | Intervention Type: OTHER; Name: Simplified cardiovascular disease management; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Simplified Cardiovascular Management Study: A Cluster-Randomized Trial to Evaluate the Effects of a Simplified Cardiovascular Management Program in Tibet, China and Haryana, India
Brief Summary: The goal of this study is to develop, pilot test, and evaluate a highly simplified but guideline-based program for cardiovascular management for application in resource-scarce settings. The study aims to assess the effects of implementing a simple low-cost cardiovascular management program for high-risk individuals, delivered by primary care providers (PCPs) or community health workers (CHWs), on the proportion of patients appropriately treated with diuretics as well as a number of secondary outcomes in resource-scarce Tibet, China and Haryana India.


Options:
A: Arm Label: without CDSS; Type: NO_INTERVENTION; Interventions: Other: CDSS | Arm Label: with CDSS; Type: EXPERIMENTAL; Interventions: Other: CDSS | Intervention Type: OTHER; Name: CDSS; Assigned to Arm(s): with CDSS, without CDSS
B: Arm Label: A - coded unit ID; Type: EXPERIMENTAL; Interventions: Other: clinical decision support | Arm Label: B - coded unit ID; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: clinical decision support; Assigned to Arm(s): A - coded unit ID
C: Arm Label: Multi-modal practice intervention; Type: N/A; Interventions: Behavioral: HeartAge intervention | Arm Label: Usual care; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: HeartAge intervention; Assigned to Arm(s): Multi-modal practice intervention
D: Arm Label: Control (Usual Care); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Simplified cardiovascular disease management | Intervention Type: OTHER; Name: Simplified cardiovascular disease management; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of the Effects of Internet-based Cognitive Behavior Therapy on Depression and Anxiety in Patients With a Previous Myocardial Infarction
Brief Summary: The overall aim and primary objective is to evaluate the effects on level of depression and anxiety of an Internet-based CBT-program in depressed and/or anxious patients after a myocardial infarction (MI).


Options:
A: Arm Label: Cognitive Behavior Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavior Therapy, Other: Heart Failure Self-care Education | Arm Label: Usual Care; Type: OTHER; Interventions: Other: Heart Failure Self-care Education | Intervention Type: BEHAVIORAL; Name: Cognitive Behavior Therapy; Assigned to Arm(s): Cognitive Behavior Therapy | Intervention Type: OTHER; Name: Heart Failure Self-care Education; Assigned to Arm(s): Cognitive Behavior Therapy, Usual Care
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavior therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supportive Stress Management | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive behavior therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Supportive Stress Management; Assigned to Arm(s): 2
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Psycho edcuactional support; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational support | Intervention Type: BEHAVIORAL; Name: Psychoeducational support; Assigned to Arm(s): Psycho edcuactional support
D: Arm Label: Internet-based CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based CBT | Arm Label: Treatment as usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Internet-based CBT; Assigned to Arm(s): Internet-based CBT

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of the Effects of Internet-based Cognitive Behavior Therapy on Depression and Anxiety in Patients With a Previous Myocardial Infarction
Brief Summary: The overall aim and primary objective is to evaluate the effects on level of depression and anxiety of an Internet-based CBT-program in depressed and/or anxious patients after a myocardial infarction (MI).


Options:
A: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Psycho edcuactional support; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational support | Intervention Type: BEHAVIORAL; Name: Psychoeducational support; Assigned to Arm(s): Psycho edcuactional support
B: Arm Label: Internet-based CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based CBT | Arm Label: Treatment as usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Internet-based CBT; Assigned to Arm(s): Internet-based CBT
C: Arm Label: Stress reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Transcendental Meditation | Arm Label: health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Stress reduction | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): health education
D: Arm Label: ACT-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ACT-based intervention, Behavioral: usual care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual care | Intervention Type: BEHAVIORAL; Name: ACT-based intervention; Assigned to Arm(s): ACT-based intervention | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): ACT-based intervention, Usual care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of the Effects of Internet-based Cognitive Behavior Therapy on Depression and Anxiety in Patients With a Previous Myocardial Infarction
Brief Summary: The overall aim and primary objective is to evaluate the effects on level of depression and anxiety of an Internet-based CBT-program in depressed and/or anxious patients after a myocardial infarction (MI).


Options:
A: Arm Label: Internet-based CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based CBT | Arm Label: Treatment as usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Internet-based CBT; Assigned to Arm(s): Internet-based CBT
B: Arm Label: Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: Placebo pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): Escitalopram | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo pill
C: Arm Label: Treatment for depression and anxiety; Type: EXPERIMENTAL; Interventions: Other: eHealth intervention | Arm Label: Usual care; Type: OTHER; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: eHealth intervention; Assigned to Arm(s): Treatment for depression and anxiety | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care
D: Arm Label: Omega-3 supplement; Type: EXPERIMENTAL; Interventions: Drug: Omega-3 supplement | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Omega-3 supplement; Assigned to Arm(s): Omega-3 supplement | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Pharmacist Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia
Brief Summary: The aim of this randomized controlled study is to investigate if medication reviews performed by a clinical pharmacist as part of a ward team can reduce drug related problems and reduce readmissions to hospital among elderly patients (≥65 years) with dementia and cognitive failure.

Four hundred and sixty patients will be recruited and randomized to control (usual care) and intervention group (enhanced service in which a pharmacist is part of the health care team).

Six months after the last patient of the 460 has been discharged the study will be closed. Data about the number of readmissions and visits to the emergency room will be collected during the six-month follow-up and also, the costs associated with each visit or admission. Time until institutionalization will be compared between intervention group and control group.


Options:
A: Arm Label: Medication review; Type: EXPERIMENTAL; Interventions: Other: Medication review | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Medication review; Assigned to Arm(s): Medication review
B: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
C: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pharmacist intervention; Type: EXPERIMENTAL; Interventions: Behavioral: multidisciplinary treatment | Intervention Type: BEHAVIORAL; Name: multidisciplinary treatment; Assigned to Arm(s): Pharmacist intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Manipulative Treatment of Children With Neck and Back Pain. A Randomised Controlled Trial of 1200 Children From 3rd to 7th Grade
Brief Summary: The purpose of this study is to determine the effect of manipulative treatment of children with neck and back pain. Because manipulation is the most frequently used treatment of musculoskeletal complaints in children, and an increasing number of Danish children see a chiropractor, it appears obvious to start the search for evidence by examining the effect of this treatment.


Options:
A: Arm Label: Chiropractic + Exercise; Type: EXPERIMENTAL; Interventions: Other: Chiropractic + Exercise | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Chiropractic + Exercise; Assigned to Arm(s): Chiropractic + Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise
B: Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Qigong exercise; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: activity training | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: activity training | Intervention Type: OTHER; Name: activity training; Assigned to Arm(s): 1, 2
D: Arm Label: Treatment with manipulation; Type: EXPERIMENTAL; Interventions: Procedure: Advice and exercise-based treatment plus joint manipulation | Arm Label: Treatment without manipulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Advice and exercise-based treatment | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment plus joint manipulation; Assigned to Arm(s): Treatment with manipulation | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment; Assigned to Arm(s): Treatment without manipulation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Randomized Study with Cisplatinum and Conventional or Adaptive High Dose Radiotherapy for Advanced Head and Neck Cancer
Brief Summary: This Phase III trial aims to:

Explore the impact of pre-treatment information and radiation dose redistribution on locoregional control in patients with locally advanced SCCHN.

The dose to the primary tumor with margins, based upon PET and CT information, will be inhomogeneously increased to a tumor dose between 70 and 84 Gy with decreasing dose towards the edges of the irradiated area.

To determine the toxicity of combined modality treatment (cisplatin) with standard dose distribution versus combined modality treatment (cisplatin) with adaptive inhomogeneous radiation dose distribution.


Options:
A: Arm Label: Cisplatinum + conventional RT; Type: ACTIVE_COMPARATOR; Interventions: Drug: cisplatinum, Radiation: Conventional radiotherapy | Arm Label: Cisplatinum + adaptive high dose RT; Type: EXPERIMENTAL; Interventions: Drug: cisplatinum, Radiation: Adaptive radiotherapy | Intervention Type: DRUG; Name: cisplatinum; Assigned to Arm(s): Cisplatinum + adaptive high dose RT, Cisplatinum + conventional RT | Intervention Type: RADIATION; Name: Conventional radiotherapy; Assigned to Arm(s): Cisplatinum + conventional RT | Intervention Type: RADIATION; Name: Adaptive radiotherapy; Assigned to Arm(s): Cisplatinum + adaptive high dose RT
B: Arm Label: Nivolumab + Ipilimumab; Type: EXPERIMENTAL; Interventions: Drug: Nivolumab, Drug: Ipilimumab | Arm Label: Placebo + Ipilimumab; Type: EXPERIMENTAL; Interventions: Drug: Ipilimumab, Drug: Placebo | Intervention Type: DRUG; Name: Nivolumab; Assigned to Arm(s): Nivolumab + Ipilimumab | Intervention Type: DRUG; Name: Ipilimumab; Assigned to Arm(s): Nivolumab + Ipilimumab, Placebo + Ipilimumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + Ipilimumab
C: Arm Label: CETUXIMAB AND DASATINIB; Type: EXPERIMENTAL; Interventions: Drug: Cetuximab, Drug: Dasatinib | Intervention Type: DRUG; Name: Cetuximab; Assigned to Arm(s): CETUXIMAB AND DASATINIB | Intervention Type: DRUG; Name: Dasatinib; Assigned to Arm(s): CETUXIMAB AND DASATINIB
D: Arm Label: ARM 1 CRT; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cisplatin | Arm Label: ARM 2 PRT; Type: EXPERIMENTAL; Interventions: Drug: Panitumumab | Intervention Type: DRUG; Name: Panitumumab; Assigned to Arm(s): ARM 2 PRT | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): ARM 1 CRT

Answer: A